News, Events, Publications and Presentations

35 Items
7th Jan 2021

Preliminary results from Carbalive and Dialive trials signal potential for new therapies to treat decompensated cirrhosis and reverse liver failure
7th Jan 2021

The ALIVER Consortium announces positive results from Phase 2 equivalent trial of the novel liver dialysis device, Dialive™
7th Jan 2021

The CARBALIVE Consortium announces positive results of a Phase 2 equivalent trial of engineered macroporous carbons as a novel treatment for cirrhosis
27th Aug 2020

Yaqrit as part of the ALIVER Consortium announces completion of first randomised controlled study of DIALIVE
1st Jul 2020

Journal of Hepatology: Toll-like receptor 4 is a therapeutic target ofr prevention and treatment of liver failure
28th May 2020

New England Journal of Medicine: Acute-on-chronic liver failure
9th Jun 2016

Nature Reviews Disease Primers: Acute-on-chronic liver failure
1st Jun 2013

Gastroenterology: Acute-on-Chronic Liver Failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis
1 2 3 4

Our Companies

Therapeutic for acute-on-chronic liver failure

Extracorporeal liver support for acute-on-chronic liver failure

Advanced microbiome therapeutic to restore gut health

Treatment and prevention of recurrence of hepatic encephalopathy